Home to 1.3 billion people, India is a country in South Asia that nearly completely covers the Indian subcontinent and is the most populous democracy in the world. India is neighbored by Pakistan, China, Nepal, Sri Lanka, Bangladesh and Myanmar and has been known for cultural and economic exchanges for more than a millennium. Since its independence in 1947, India has become an economic powerhouse although the nation still struggles with poverty, corruption, malnutrition and a gap in quality between private and public healthcare facilities.
Tuberculosis in the country
India has been called the country ‘worst affected’ by Tuberculosis, with 480.000 TB-related deaths annually, making up about a quarter of all global TB deaths. Recent efforts have attempted to reduce the impact of the TB-epidemic by bridging the gap in quality between private and public healthcare providers, yet much work remains to be done.
KNCV Activities in the country
India is a country where the Challenge TB program is active. Challenge TB is USAID’s flagship global mechanism for implementing USAID’s TB Strategy and is led by KNCV Tuberculosis Foundation, who also led USAID’s previous TB Control projects TB CARE I, TB CAP and TBCTA.
In Chennai India, the public and private sectors and NGOS have been brought together in the EQUIP project as part of a project with Eli Lilly. EQUIP, which stands for ‘Enhanced use of Quality drugs and Utilization of Innovative Diagnostics for TB Management in the Private Sector’, is creating a public-private partnership to ensure that private sector health providers and their patients will have access to free TB testing with the latest technology. The goal of the EQUIP project, is the development of a replicable model for public private collaboration with an NGO as an interface agency. The interventions were developed in participation with private providers and patients, and continuously monitored and shaped during implementation.